Tenecteplase vs alteplase as bridging thrombectomy in ischemic stroke patients: a systematic review and meta analysis

Abstract Background Alteplase (ALT) is the standard medical therapy, and also approved by food and drug administration (FDA) for acute ischemic stroke (AIS) patients who present within 4.5 h of symptom onset. However, several randomized controlled trials (RCTs) have reported that tenecteplase (TNK)...

Full description

Saved in:
Bibliographic Details
Main Authors: Salim Harris, Al Rasyid, Mohammad Kurniawan, Rakhmad Hidayat, Taufik Mesiano, David Pangeran, Marcellinus Michael
Format: Article
Language:English
Published: SpringerOpen 2025-08-01
Series:The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:
Online Access:https://doi.org/10.1186/s41983-025-01014-y
Tags: Add Tag
No Tags, Be the first to tag this record!